Equities

Kimia Farma Tbk PT

KAEF:JKT

Kimia Farma Tbk PT

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (IDR)600.00
  • Today's Change-5.00 / -0.83%
  • Shares traded285.50k
  • 1 Year change-19.46%
  • Beta-0.1191
Data delayed at least 10 minutes, as of Nov 15 2024 09:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of IDR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income------
Depreciation/depletion------
Non-Cash items------
Cash taxes paid, supplemental(56912)49,614147,603
Cash interest paid, supplemental(582385)(508373)(606813)
Changes in working capital(3775851)(3433919)(3746000)
Total cash from operations(364575)403,339(223925)
INVESTING
Capital expenditures(744700)(906584)(659252)
Other investing and cash flow items, total22,200477,19610,798
Total cash from investing(722501)(429389)(648454)
FINANCING
Financing cash flow items162,9601,385,105(10473)
Total cash dividends paid----(702)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(434987)74,033375,526
Total cash from financing(272027)1,459,138364,351
NET CHANGE IN CASH
Foreign exchange effects7019,5066,516
Net change in cash(1358403)1,442,594(501513)
Net cash-begin balance/reserved for future use2,191,075748,4811,249,994
Net cash-end balance/reserved for future use832,6722,191,075748,481
SUPPLEMENTAL INCOME
Depreciation, supplemental------
Cash interest paid, supplemental(582385)(508373)(606813)
Cash taxes paid, supplemental(56912)49,614147,603
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.